![]() |
|
|
Vol. 282, Issue 3, 1345-1350, 1997
Department of Veterinary PathoBiology, University of Minnesota, St.
Paul, Minnesota
Nerve growth factor (NGF) induces a relatively long-term hyperalgesia
in rats, whereas substance P (SP) N-terminal fragments, like SP(1-7),
produce a long-lasting antinociception in mice. We used various
nociceptive assays to compare the effects of these compounds on pain
transmission when injected intrathecally (i.t.) in mice, and to
determine whether either compound affects the action of the other. NGF
produced thermal hyperalgesia when injected i.t. in mice 24 and 48 hr
before testing by the tail-flick assay. During this same interval, NGF
elicited no effect on the response to von Frey fibers or on chemically
induced nociception measured by the writhing assay. In contrast to NGF,
SP(1-7) had no effect on tail-flick latencies but induced
antinociception in the writhing assay 24 hr after injection. When
administered 2 hr before NGF, SP(1-7) antagonized the thermal
hyperalgesic effect of NGF in a dose-related fashion, despite the
inability of SP(1-7) to alter tail-flick latency when administered
alone. NGF, in turn, antagonized the antinociceptive effects of
SP(1-7) in the writhing assay. The D-amino
acid-substituted analog, D-SP(1-7), failed to mimic the
antinociceptive effect of SP(1-7) or to alter the hyperalgesic effect
of NGF, which indicated a stereoselective action of SP(1-7). D-SP(1-7), that inhibits SP(1-7) binding, did reverse the ability of
SP(1-7) to antagonize NGF-induced hyperalgesia, consistent with its
action as a SP N-terminal antagonist. Mutual antagonism between NGF and
SP may reflect modulatory roles of these endogenously occurring
peptides during chronic pain when N-terminal metabolites of SP may
accumulate.